Nwla Oncology Consultants Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-07-2024
- Paid Up Capital ₹ 1.00 M
as on 02-07-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 99.49%
(FY 2022)
- Ebitda 99.48%
(FY 2022)
- Net Worth -1.49%
(FY 2022)
- Total Assets -2.83%
(FY 2022)
About Nwla Oncology Consultants
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Namita Kharbanda and Manish Dhawan serve as directors at the Company.
- CIN/LLPIN
U85300TN2019PTC128187
- Company No.
128187
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nwla Oncology Consultants?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Namita Kharbanda  | Director | 25-Mar-2019 | Current |
Manish Dhawan  | Director | 25-Mar-2019 | Current |
Financial Performance and Corporate Structure Insights of Nwla Oncology Consultants.
Nwla Oncology Consultants Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 99.49% increase in profit. The company's net worth dipped by a decrease of 1.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nwla Oncology Consultants?
Unlock access to Nwla Oncology Consultants's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Metacognition Systems Thalamus Irwine Ll P
Active
3 years 7 months Namita Kharbanda is a mutual person
Thalamus Irwine Power Systems Private Limited
Active 2 years 9 months Namita Kharbanda is a mutual person
Iesg International Export Solutions Private Limited
Active 2 years 9 months Namita Kharbanda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nwla Oncology Consultants?
Unlock and access historical data on people associated with Nwla Oncology Consultants, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nwla Oncology Consultants, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nwla Oncology Consultants's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
